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Graft-versus-host  (GVH) 1 assay is one of many methods of measuring the immu- 
nological activity  of  lymphoid cells  against  histocompatibility antigens.  It  is  the 
most suitable in vivo method when a  quantitative comparison of cell populations is 
required. After immunization with allogeneic antigen the GVH activity of an animal's 
lymphocytes is usually increased. However, in strain combinations of mice involving 
a  difference at the H-2 locus, the augmentation of GVH activity after immunization 
(the  "factor of immunization")  is very slight; the augmentation increases with the 
weakness of the antigenic barrier (1, 2). 
In the rat, GVH activity can be satisfactorily measured by a lymph node weight 
assay (3, 4). Using this assay it has been found that to produce an arbitrarily chosen 
lymph node enlargement of 10.0 ing requires 50-100 times as many cells in weak as 
compared with strong strain combinations. In the present experiments the effect of 
specific allogeneic immunization  on  the  GVH  activity of lymphoid cells has  been 
investigated using  several weak  and  strong  combinations  of  the  inbred  rat.  The 
paradoxical inverse relationship between antigenic strength and the factor of immu- 
nization has been confirmed. 
In further  experiments the possible effects of  other variables on  the factor 
of immunization have been  tested, namely:  (a) the schedule of immunization 
used;  (b)the  interval  elapsing  between  immunization  and  assay;  and  (c) 
the population of  cells used for  assay. Lastly,  an  attempt  has  been  made  to 
test a  suggestion (5) that the specific inhibitory effect of humoral alloantibody 
might be responsible for the low factor of immunization in strong strain com- 
binations. 
Methods 
Rats.--The GVH activities of lymphocytes from immune and nonimmune donors matched 
for age and sex were compared. The following strain combinations  were used (where X --* Y 
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denotes the assay of lymphocytes from inbred strain X  in (X X  Y) F1 hybrids). AS --~ AS2, 
AS2 --~ AS, AS---~ BN, and F--+BN  (all AgB different); AS--*F and F--*AS  (AgB identi- 
cal). In further exeriments, cells from (AS X  BN) F2 hybrids selected  to  be AgB  heterozy- 
gotes after serological screening were assayed in (AS X  BIN-) F1 hybrids. In this case the GVH 
reaction was against half the minor loci, on average, at which the AS and BN strains differ. 
GVH Assay.--The popliteal lymph node assay has previously been described in detail (4). 
In the present experiments at least four footpads were injected with each of three graded 
doses of lymphocytes. Thus each estimate of GVH activity is based on the reaction of at least 
12 lymph nodes. In the AgB-identical strain combinations, doubling doses were used, usually 
starting at 20  X  106;  in the AgB-different combinations, tripling doses were used, usually 
starting at 0.33 X  106. 
Preparation of thoracic duct lymphocytes  (TDL) and spleen cells were as previously de- 
scribed (4). Lymph node cells were prepared as were spleen cells. 
X-Irradiation.--In some experiments donors were subjected to 300 R  of whole body X-ir- 
radiation 24 hr before immunization. Rats were irradiated singly in Perspex cages from a 
225 kv source delivering 17 R/rain. 
Alloantibody Titration and A gB Classification.--Serum  was  obtained from  the irradiated 
donors before immunization, 6  days after immunization, and at the time of assay of their 
lymphocytes. Nonirradiated, immunized control rats were bled at the same time. Hemagglu- 
tinating alloantibody was titrated using 3-fold serum dilutions in phosphate-buffered saline 
(PBS). To 2 drops of serum dilution was added 1 drop of a  2% erythrocyte suspension in 9 
parts of 6% dextran (Glaxo Laboratories, Ltd., Greenford, England) and 1 part of normal F1 
rat serum. Macroscopic reading was after a 2 hr incubation at 37°C. The screening of (AS X 
BN) F2 rats for the identification of AgB heterozygotes was performed using a similar tech- 
nique. Erythrocytes from the unknown rats were titrated against an AS anti-BN serum and 
a  BN anti-AS serum. With the aid  of appropriate control erythrocytes  (BN,  AS,  and F1) 
double-reacting erythrocytes could be easily identified. 
Immunization.--Two skin allografts with an interval of at least 2 wk between them was 
the standard immunization procedure. The second set tempo of rejection of the second graft 
showed that some degree of immunization had already been produced by the first graft. Some 
groups were "boosted" after skin grafting by the subcutaneous injection of 100  ~(  106 allo- 
geneic spleen and lymph node cells.  Three injections were given at weekly intervals and each 
dose was distributed between the four footpads and the angles of the mouth.  Further groups 
of rats were immunized solely by one injection of 100 X  106  spleen and lymph node cells dis- 
tributed equally between the four footpads. Unless otherwise stated, the lymphoid cells for 
GVH assay were removed from the immune donors between 10 days and 3 wk after  the last 
immunization. 
Validity of Comparing Immune ond Nonimmune  Cells by GVH Assay.--Quantitative com- 
parison  of  the  GVH activity of immune and nonimmune populations depends  (a)  on the 
slopes of the dose-response lines being similar and (b) the tempos of the lymph node responses 
being similar. Condition (a) could be seen to be fulfilled with each acceptable assay. The time 
course of the popliteal lymph node enlargement was studied in preliminary experiments in 
both weak and strong combinations. Graded doses of TDL were given to a large number of 
recipients. Groups of four at each dose level were killed at days 3, 5, and 7 after injection. In 
the strong combination there was no difference in the tempo of the responses produced by the 
immune and  nonimmune populations.  In weak  strain combinations immune cells did  not 
produce a more rapid response but with high doses the lymph nodes ceased enlarging by day 
5. In fact, with these immune populations dose saturation corresponded to a lower lymph node 
response than in nonimmune populations or in strong strain combinations. However, accept- 
able assays could be performed by using smaller doses of immune cells which gave the same 
gradation of response as did nonimmune cells. 940  GRAFT-VERSUS-HOST  ACTIVITY  AFTER  IMMUNIZATION 
In another local GVH system (that  after the injection of lymphocytes into guinea pig 
skin) immune and nonimmune cells have also been found to produce reactions which develop 
at a similar tempo (6). 
RESULTS 
The  GVH activity of lymphoid cells from putatively immune donors  was 
assayed in  comparison with  cells  from matched,  nonimmune rats.  The result 
of such  an assay is  expressed as a  potency ratio:  the ratio of the number of 
nonimmune  cells  to  the  number  of immune cells  required  to  produce  equal 
lymph node enlargement.  In the case of immune vs. nonimmune assays this 
potency ratio is called the factor of immunization  (F.I.). 
Series A: A gB-Identical  Strain Combinations  (See Table I) 
Group 1: Immunization with Two Skin Grafts (Assay of TDL).--Four assays 
were  performed  in  each  of  the  reciprocal  strain  combinations AS  --~ F  and 
F --~ AS. In all eight assays the GVH activity of immune TDL was increased 
above that of nonimmune, but the mean activity was only doubled by immuni- 
zation. 
Group 2: Immunization with Two Skin Grafts plus Boosting  with Allogeneic 
Lymphoid Cells (Assay of TDL).--Four  assays were performed in  the combi- 
nation AS --~ F.  The mean F.I.  was higher  than without boosting and  there 
was no overlap in the results of individual assays. 
Group  3:  Immunization  with  Two Skin  Grafts  (Assay  of Spleen  Cells).-- 
Five assays were performed in  the  combinations F  --+ AS.  The consequence 
of assaying spleen cells rather than TDL was higher F.I., which again did not 
overlap with group 1. 
Group 4:  Immunization with Two Skin Grafts plus Boosting with Allogeneic 
Lymphoid  Cells (Assay  of Spleen  Cells).--In  this  situation  the  factors  by 
which group 2 and group 3 differed from group 1 were imposed together. Four 
assays in  the  combination AS --~ F  gave very high  F.I.  with  a  mean  of 52. 
These F.I. were clearly much greater than in any of the other groups. 
Taken as a  whole  the results of groups  1-4 indicate that  the F.I. in weak 
strain  combinations  depends  on  the  immunization  procedure  (even two  skin 
grafts  are  not  optimal)  and  also  on  the  population  of  cells  used  for  assay. 
When  the  results  of groups  2  and 4  are  analyzed,  it  can be estimated  that 
before immunization  spleen  cells have slightly less  GVtt activity than  TDL 
(0.5-1.0  times the activity) but after immunization they are 7-10 times more 
active. 
Group 5: AgB-Helerozygous  (AS X  BN) F2 Donors Immunized with Two Skin 
Allografts  (F1) plus  Boosting  with Allogeneic  (FI) Lymphoid  Cells  (Assay  of 
TDL).--In  this situation the GVH activity is against the antigens present in 
the F1 recipients but not the F2 donor, i.e.,  antigens determined by the minor WILLIAM  L.  FORD  AND  ~[ORTEN  SI~ONSEN  941 
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loci for which the donor happens to be homozygous. Although the donors will 
on the average be homozygous at half the minor loci the proportion will vary 
from  rat  to  rat.  For  this reason it might  have  been  misleading  to  work  out 
the F.I. on each (arbitrary) immune and nonimmune pair. The results of four 
assays were combined (Fig.  1)  and  the overall mean dose-response lines were 
drawn.  By  this method  the overall F.I. was  7.7,  which  was  twice as high  as 
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FIG. 1.  TDL from AgB heterozygous  (AS X  BN) F2 donors injected into feet of (AS X 
BN) F~ recipients.  Each point is geometric mean response of four lymph node weights.  O-- 
TDL from four nonimmtme donors. X--TDL from four immune donors. Responses not sig- 
nifieantly greater than those produced by same dose of syngeneic F1 TDL have been omitted. 
Assay lines have been drawn through mean dose/mean response point of each group with a 
slope equal to the mean slope of the lines of best fit for each group.  Immune cells were 7-8 
times more potent than nonimmune cells. 
the  F.I.  obtained  by  assay  of  TDL  in  the  "ordinary"  weak  combinations 
(group 2)  and also the F.I. in strong strain combinations (vide infra). 
Series B: A gB-Different Strain Combinations 
Group 1: Immunization  with  Two  Skin  Grafts (Assay  of  TDL).--Three 
assays were performed in each of three strain combinations (AS ~  AS2, AS2 --~ 
AS, AS --~ BN).  In all assays the GVH activity of immune TDL was greater 
or the  same as nonilnmune  TDL  (Table II).  The mean  F.I.  of  1.4  was very 
low and was probably lower than the F.I. of corresponding assays in the weak 
combinations (P  <  0.01). 
Group 2: Immunization  with  Two Skin Grafts plus  Boosting with Allogeneic WILLIAM L.  FORD  AND  MORTEN  SIMONSEN  943 
Lymphoid Cells (Assay of Spleen Cells).--Four  assays were performed in  the 
combination AS2 ---> AS. In every case "immune" cells had less GVH activity 
than nonimmune, giving a mean F.I. of 0.60 (Table II). The F.I. was signifi- 
cantly lower  than  in  the  results  of the  assays  in  group  1.  The finding that 
assaying spleen cells instead  of TDL and boosting with lymphoid cells after 
grafting decreases the  F.I.  in  strong  combinations is  in  striking  contrast  to 
the situation in weak strain combinations where imposition of these two factors 
increases the F.I. by a factor of about 25. 
Group 3: Assay  of Lymphoid Cells at  Varying Intervals after a Single Im- 
munizing Injection (Table III):--(a) In three experiments F  donors were im- 
munized by a  single  intraperitoneal  injection of  100  X  106 BN  spleen  and 
lymph node cells. When spleen cells were taken 4 days after immunization and 
assayed against normal F  spleen cells the F.I. were variable but certainly did 
TABLE  II 
Factor of Immunization  in AgB-Different Strain Cnmbinations 
Strain 
o  combinations 
B  1  AS ~  AS2 
B 1  AS2 --+ AS 
B  1  AS ~  BN 
B 2  AS2 --+ AS 
Cells 
used 
for 
assay 
FDL 
FDL 
FDL 
;pleen 
GVH 
activity 
of non- 
immune* 
,.63 X  106 
1.1X 106 
,.42 X  106 
1.4X 106 
Immunization 
procedure 
2 skin grafts 
2 skin grafts 
2skin grafts 
2 skin grafts 
+lymphoid 
cells~ 
Results of individual 
assays 
(F.L) 
1.6, 1.2,  1.0 
1.3,  1.5, 1.3 
1.6,  2.0,  1.0 
0.42, 0.94, 0.39, 0.86 
Geometric 
mean of F.L 
1.2  t  Overall 
1.4  mean 
1.5  =  1.4 
0.6 
Significance 
F.I. is less 
than B-I 
(P <  0.001) 
* No. of cells required to produce lymph node enlargement to 10.0 mg; inversely related to strength of combination. 
Three injections  of 100 X 10e allogeneic lymph node and spleen cells given subcutaneously at weekly intervals. 
not indicate any exceptional increase in GVH activity at this stage. Comparison 
of methyl green pyronin-stained films of the immune and nonimmune spleen 
cells showed an obvious increase in the number of large pyroninophilic cells in 
the immune suspensions. 
(b)  In three experiments donors were immunized by the injection into the 
four footpads of a  total of 100  X  106 BN spleen and lymph node cells.  Mter 
4  days the draining lymph nodes (popliteal and brachial)  were removed and 
cell  suspensions  assayed  against  cells  from  the  same  lymph  nodes  of  non- 
immune rats. As in the previous subgroup little or no increase in GVH activity 
was found in these lymph node cells despite the fact that the lymph nodes were 
enlarged in reaction to the immunization and contained a high proportion of 
large pyroninophilic cells. 
(c)  In four experiments F  donors were immunized by injection into the four 
footpads of a total of 100 X  106 (F X  BN) F1 hybrid spleen and lymph node 
cells.  After between 3 and 4 wk, when the reaction in the draining nodes had 944  GRAFT-VERSUS-HOST ACTIVITY AFTER  IMMUNIZATION 
subsided,  cells prepared from the draining nodes were assayed against pooled 
lymph  node  cells  from  nonirmnune  donors.  At  the  same  time  nondraining 
lymph node cells from the immune donors were assayed against nonimmune 
pooled lymph node cells. There was no significant difference between the GVH 
activity of the draining and nondraining lymph node cells,  and although the 
F.I. was very variable, the mean value of less than unity suggested a tendency 
for the  GVH activity of lymph node cells  to be depressed below normal,  as 
in group 2. 
The experiments of series B fully achieved their object, which was to show 
that the very low F.I. found in the standard experimental situation (group l) 
was not increased by altering the time between imnmnization and assay,  the 
schedule of immunization, or the population of lymphoid cells assayed. 
TABLE III 
Factor  of Immunization in AgB-Different Strain Combinations 
B-3  (c) 
Strain 
Group  combin- 
ations 
B-3  (a)  F --* BN 
B-3  (b)  F ~  BN 
F~BN 
Cells used 
for assay 
Spleen 
Lymph node 
Lymph node 
Immunization 
procedure 
Allogeneic  (BN) 
lymphoid cells i.p. 
Allogeneic  (BN) 
lymphoid ceils 
into footpads 
(BN X F) F1 hybrid 
lymphoid cells 
into footpads 
I 
Interval  ; 
between  Results of individual 
immn-  ;  assays 
nization  (F.I.) 
and assay 
4 days 
4 days 
3-4 wk 
0.93,  1.6, 0.73 
1.5,  0.72, 2.8 
0.69,0.58,1.3,0.77, 
0.47, 0.68,  1.1, 0.62 
Geo- 
metric 
mean 
1.0 
1.4" 
0.80* 
0.68~ 
Immunized  donor given single injection of 100 X 106 spleen and lymph node cells. 
* Draining lymph node cells assayed against nonimmnne lymph node cells. 
~: Nondraining lymph node cells assayed against nonimmune lymph node cells, 
Series C:  Factor of Immunization in Rats Incapable of an Alloantibody Response 
The low F.I.  in  strong strain  combinations may be a  consequence of the 
high frequency of  antigen-sensitive  cells  in  nonimmune  animals  specifically, 
directly against a particular complement of strong histocompatibility antigens 
(1,  2). An alternative explanation is that the humoral alloanfibody response, 
which  is  readily  detectable  against  strong  histocompatibility  antigens,  is 
responsible  for  partly  inhibiting  the  development  of  the  cellular  immune 
response,  a  process which  might  be  described as  partial  immunological  en- 
hancement. This latter possibility is not, of course, at all inconsistent with the 
first;  both mechanisms  may operate. However, if inhibition by alloantibody 
were the sole factor responsible for the low F.I. in strong strain combinations, 
then it would be predicted that immunization of an animal which had been 
manipulated so as to be capable of a cellular but not a humoral response would 
result in a raised F.I. WILLIAM  L.  FORD  AND  MORTEN  SIMONSEN  945 
A critical dose of whole body X-irradiation inhibits the humoral alloantibody 
response  of  mice  without  detectably prolonging  skin  allograft  survival  (7). 
It was found empirically that a suitable dose of X-irradiation for this purpose 
in AS and F  rats was 300 rads. The survival of skin allografts applied the day 
after irradiation was not detectably prolonged and the alloantibody response 
to (BN X  AS) Fi hybrid lymphoid cells injected into AS rats was completely 
suppressed.  Seven nonirradiated immunized control rats all produced hemag- 
glutinating alloantibody at titers of 1/27 or 1/81  on day 6 and at 3 wk after 
immunization, whereas none of seven irradiated,  immunized rats had detect- 
able antibody on either day. 
In the first three experiments (Table IV, C-I)  F  rats were immunized with 
a  BN skin graft 1 day after 300 rads of whole body X-irradiation and their 
TDL were assayed between 10 days and 3 wk later. This assay was done by 
o 
C-1 
02 
TABLE IV 
1~ 7ect on F.I. of 300 Rads of Whole Body X-Irradlation  24 hr before Immunization 
Strain 
combin- 
ation 
F -*BN 
~S -~ BI~ 
GVH 
activity of 
normal 
TDL* 
0.50 X  lO  s 
0.42  X  10  e 
Immunization 
procedure 
Single skin allograft 
100 X  106  (AS X  BN)FI 
lymphoid cells s.c. 
F,I. 
i.e. irrad. 
immune 
irrad, 
nonimmune 
1.0,  1.6, 0.44 
0.84,  1.8 
F.I. in 
non- 
:radiatel 
controls 
1.0,  1.5 
Potency ratio of 
irrad, immune 
normal 
(nonimmune) 
0.77, 0.31, 0.23 
0.33, 0.40 
TDL used for assay. 
* No. of TDL required to produce lymph node enlargement to 10.0 mg inversely related  to strength of com- 
bination. 
comparison with irradiated, nonimmune F donors and also untreated F donors. 
The  thoracic  duct  outputs  of  the  two  irradiated  groups  were  depressed  to 
about  10%  of normal  and  the residual TDL had lower GVH activity than 
normal. The F.I. was variable but since the highest value was  1.6  there was 
no  suggestion  that  irradiation  before immunization  had  produced  a  higher 
F.I. than in the experiments of series B. 
In other experiments (Table IV, C-2) AS rats were immunized 1 day after 
300  rads  of whole body X-irradiation by injection into  the footpads of  100 
X  106 (AS  X  BN) F1 spleen and lymph node cells. The GVH activity of their 
TDL obtained 3 wk after irradiation was compared to that of TDL from ir- 
radiated,  nonimmune donors.  TDL from two other control groups  were  in- 
cluded,  i.e.  (a) nonirradiated  and  immunized  and  (b) untreated.  The results 
of these assays were very similar to those of the first group. Whole body X-ir- 
radiation  is followed by a  low output of TDL of diminished  GVH activity. 
However, the F.I.  remains low as in the  experiments of series B. It was re- 
markable  that  although  irradiated,  immunized  rats  rejected  skin  allografts 946  GRAFT-VERSUS-HOST ACTIVITY AFTER  IMMUNIZATION 
at the usual tempo, the GVH activity of their TDL was in all cases less  than 
that of TDL from normal (nonimmune) donors. 
DISCUSSION 
The object of the present experiments was  to measure the change in GVH 
activity after specific alloimmunization  (expressed as  the factor of immuni- 
zation)  in a  number of experimental situations.  In the mouse (1)  and in the 
chicken (8) the F.I. is greater when the antigenic disparity is less; when a strong 
histocompatibility difference is involved it  is near unity.  The present results 
fully confirm earlier results  in  less  satisfactory assay  systems  (9,  10)  which 
hinted that the dependence of F.I. on antigenic strength is valid in the rat also. 
The most dramatic difference in F.I. between weak and strong strain con> 
binations was found when spleen cells  were assayed after immunization with 
two  skin  allografts  followed  by  boosting  injections  of  allogeneic  lymphoid 
cells. In the weak combination the F.I. of about 50 is very similar to the values 
from comparable experiments in the mouse (1). In the strong combination the 
F.I.  of less  than unity has also a  precedent in mice  (11,  12).  These workers 
attributed  the  depression  of  GVH  activity  to  immunological  enhancement. 
In  the  present  experiments  there  are  no  grounds  for favoring enhancement 
over the  alternative  explanation  of partial  tolerance.  However, preliminary 
experiments  (Simonsen,  M.,  unpublished  data)  designed  to  test for  the  en- 
hancing  effect  of  AgB-hemagglutinating  antisera  in  both  directions  of  the 
AS-AS2  combination have been performed. Normal  spleen  cells were mixed 
with equal volumes of undiluted antisera against the recipient antigen or, for 
control, with normal sera before injection into the hind feet. No difference in 
the popliteal lymph node enlargement was observed between test and control 
groups. 
After two skin allografts had been rejected the F.I. in a weak combination 
could be further increased by boosting with allogeneic lymphoid cells, especially 
if spleen  cells  were assayed.  The particular effectiveness of living peripheral 
lymphoid cells  in allogeneic immunization as compared with skin grafts may 
reflect  their  high  content  of  histocompatibility  antigen  (13,  14)  and  their 
widespread distribution in  the spleen and lymph nodes before their destruc- 
tion by a host-vs.-graft reaction (15). 
Spleen cells, as a source of donor cells for the GVH assay, gave a higher F.I. 
than did TDL in weak combinations. About half of the small lymphocytes in 
the spleen belong to the same recirculating pool as do the great majority of 
TDL  (15).  Under  the  conditions  of these experiments the greatly increased 
GVH activity of spleen cells after immunization can be attributed mainly to 
the nonrecirculating population in the spleen. This conclusion can be compared 
to  recent data  on immunological memory to conventional antigens  (17,  18). 
Although it was confirmed that immunological memory is carried by recircu- WILLIAM  L.  FORD  AND  MORTEN  SIMONSEN  947 
lating cells (19)  these studies showed that the antigenically stimulated lymph 
node responds to a second injection of antigen more quickly and more strongly 
than does the contralateral node. Apparently immunological memory is not 
confined to recirculating lymphocytes but is also strongly represented in the 
nonrecirculating population of a lymph node. 
In  AgB-different (strong)  strain  combinations  the  several  factors  which 
influenced the F.I. in weak combinations were completely ineffective in raising 
the F.I. It was particularly remarkable that when draining lymph nodes were 
assayed 4  days after subcutaneous immunization at  the height of the large 
pyroninophilic cell response the F.I. was near unity. By contrast, a  large in- 
crement of stimulation in mixed-lymphocyte culture was found when spleen 
cells were removed 4 days after intraperitoneal immunization with allogeneic 
spleen cells  (20) but in a  very similar experiment (B-3[a])  no increment was 
found in GVH assay. 
The  failure of  irradiation  applied  before  immunization to  bring  about  a 
higher F.I.  suggested that the inhibitory effect of alloantibody is not solely 
responsible for the low F.I. in strong strain combinations. Of course it cannot 
be certain that partial inhibition of the cellular response did not result from 
concentrations of enhancing antibody which were too low to be detected. How- 
ever this result is especially convincing of the intrinsic limitation of the F.I. 
in strong combinations, since irradiated animals provide a  superior environ- 
ment for immune responses mediated by transferred cells (21);  it is reasonable 
to suppose that the surviving cells reacting to the antigen would be favored 
in the same way by the extra space available in the lymphoid tissue. 
An alternative way to immunize animals incapable of a  humoral alloanti- 
body response is to use bursectomized chickens. Experiments are at present 
being performed in this laboratory to measure the F.I.  of such animals.  So 
far the F.I. has not shown any tendency to increase in bursectomized chickens 
in spite of the absence of a detectable antibody response. 
The conclusion that the limitation of the F.I. in strong combinations is a 
consequence of a  very high proportion of antigen-sensitive cells  in the non- 
immune animal (1,  2)  has been reinforced by the present experiments. This 
is quite consistent with the possibility that the cells reactive to strong antigens 
generate predominantly effector cells  (which may not count in GVH assay), 
whereas  the cells  reactive to weak antigens generate both  effector cells  and 
more of themselves, thus producing high F.I. (22). 
SUMMARY 
Using a popliteal lymph node weight assay the graft-versus-host  activity of 
lymphocytes from donors immunized with allogeneic tissue has been assayed 
by comparison with that of lymphocytes from nonimmune donors. When the 
donors were immunized against weak histocompatibility antigens (non-AgB) 948  GRAFT-VERSUS-HOST  ACTIVITY  AFTER  IMMUNIZATION 
the specific GVH activity of its lymphocytes was increased.  This increase was 
greater if spleen  cells  rather  than  thoracic duct lymphocytes were the  source 
of the donor cells used for assay. The increase in GVH activity was also greater 
if the  standard  immunization  procedure  of two successive skin allografts was 
followed by three boosting injections of allogeneie lymphoid cells. 
When  donors  were  immunized  against  strong  histocompatibility :antigens 
the specific GVH activity of the  donors' lymphocytes was  slightly increased, 
was  unchanged,  or  was  actually  decreased  depending  on  the  experimental 
situation.  In donors rendered incapable of a humoral alloantibody response  by 
whole body X-irradiation,  immunization  across a  strong barrier  was followed 
by little or no increase in the specific GVH activity of TDL. In the rat,  as in 
other species,  the  increase  in  GVH  activity  after  immunization  is  inversely 
proportional to the strength of the antigenic barrier involved. 
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